GlassScriptPhysician profile
Elizabeth A Wright
NPI 1760825582
$4,234.17
in general payments reported to CMS, 2019-2025
44 companies · $742 in 2025
The $742 reported for 2025 was more than what 75% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,380 · 2022: $609 · 2023: $970 · 2024: $532 · 2025: $742.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,245.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,244.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,395.59 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $369.13 | 2021-2025 | Farxiga, Breztri, Airsupra |
| Novo Nordisk INC | $258.36 | 2021-2025 | Wegovy, Rybelsus, Ozempic |
| Bayer Healthcare Pharmaceuticals INC. | $247.52 | 2022-2024 | |
| Lilly USA, LLC | $213.61 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Corcept Therapeutics | $204.82 | 2024-2025 | Korlym |
| Biohaven Pharmaceuticals, INC. | $181.99 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $134.06 | 2021-2025 | Jardiance |
| Xeris Pharmaceuticals, INC. | $112.78 | 2021-2025 | Recorlev |
| Pfizer INC. | $106.42 | 2022-2025 | |
| Glaxosmithkline, LLC. | $77.89 | 2021 | |
| Merck Sharp & Dohme LLC | $75.77 | 2021-2024 | Gardasil, Vaxelis, Capvaxive |
| Abbott Laboratories | $75.53 | 2021-2023 | Freestyle Libre 2 |
| Boston Scientific Corporation | $75.05 | 2021-2025 | Watchman Access System, Wavewriter Alpha Prime 16 |
| Idorsia Pharmaceuticals US INC | $48.09 | 2023 | Quviviq |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.